tadalafil has been researched along with cilostazol in 6 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (cilostazol) | Trials (cilostazol) | Recent Studies (post-2010) (cilostazol) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 1,508 | 302 | 848 |
| Protein | Taxonomy | tadalafil (IC50) | cilostazol (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.4367 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Huang, YY; Li, Z; Luo, HB; Wu, D; Wu, Y | 1 |
| Chai, S; Chen, S; Deng, L; Du, K; Shen, R; Sun, H; Sun, T; Xi, M; Xie, M | 1 |
| Albers, HJ; Coenen, DM; Cosemans, JMEM; Hagué, P; Heinzmann, ACA; Koenen, RR; Kuijpers, MJE; Nagy, M; Oggero, S; Perretti, M; van der Meer, AD; Vanderwinden, JM | 1 |
| Amin, A; Habib, HA; Heeba, GH; Othman, EM; Zahran, ME | 1 |
3 review(s) available for tadalafil and cilostazol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Cognition; Humans; Phosphodiesterase Inhibitors | 2018 |
Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alzheimer Disease; Animals; Cognition; Cyclic GMP; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases | 2022 |
3 other study(ies) available for tadalafil and cilostazol
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions.
Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Blood Platelets; Cells, Cultured; Chemokines; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Fibrin; Fibrinolytic Agents; Humans; Inflammation Mediators; Mice, Inbred C57BL; Mice, Knockout; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Platelet Activation; Platelet Adhesiveness; Signal Transduction; Tadalafil | 2021 |
Mechanistic Protective Effect of Cilostazol in Cisplatin-Induced Testicular Damage via Regulation of Oxidative Stress and TNF-α/NF-κB/Caspase-3 Pathways.
Topics: Animals; Caspase 3; Cilostazol; Cisplatin; Inflammation; Male; NF-kappa B; Oxidative Stress; Pentoxifylline; Phosphodiesterase 3 Inhibitors; Rats; Semen; Tadalafil; Tumor Necrosis Factor-alpha | 2023 |